Andreas Bosshard, co-owner and former managing director of Oertli Instrumente AG, handed over the chairmanship of the board to Andreas Schmidheini. The reorganization became effective January 1, 2020.
In 1988, Mr. Bosshard joined Oertli Instrumente AG and took over as managing director in 1989. For more than 20 years, Mr. Bosshard managed the company and led it from a local manufacture to an international success story in ophthalmic surgery. Under his leadership, Oertli launched five surgical platforms onto the market, developed two new surgical techniques for glaucoma and cataract surgery, and successfully introduced several inventions that still shape the world of ophthalmology today.
In 2010, Mr. Bosshard handed over the operational management to his two sons and concentrated on his function as Chairman of the Board.
“My father was able to let go very well, but was always there for us when we needed it. He still possesses his analytical skills and his sure instinct for what the customer really needs today as he did 30 years ago,” said Christoph Bosshard, the current CEO.
For a decade, Andreas Bosshard served as Chairman of the Board, of which his wife Rosmarie Bosshard was also an important member. “The years on the Board of Directors were very exciting for me, and I admire you, Andreas, for the way you have led the company to a true family business,” said Rosmarie Bosshard during an employee information event, thanking her husband for his commitment.
Andreas Bosshard did not miss the opportunity to recapitulate his 30 years with Oertli. Since he handed over the operational management, around 90 employees and sales companies in four countries, have joined the company.
The new Chairman of the Board is Andreas Schmidheini, who has been on the Board of Directors of Oertli Instrumente AG since 2010.
“Dear Andreas, I am aware that I am following in great footsteps, because your life’s work impresses me extraordinarily, and I admire you for it,” Mr. Schmidheini said.
Andreas Bosshard’s two sons, Christoph Bosshard, CEO, and Thomas Bosshard, Head of Marketing & Sales, are also new to the Board of Directors.
The five board members are completed by two experienced personalities from the medical technology sector; Andrea Berlinger Schwyter, owner and Chairman of Berlinger & Co. AG in Ganterschwil, and Reihold Gasper, Site Manager of B. Braun Medical AG in Escholzmatt, LU. The newly composed Board of Directors is the supreme supervisory body and as such is responsible for the long-term strategic direction of the company. This includes major investments such as the planned new building. The three-story building will provide urgently needed space, especially for logistics, and offer sufficient space for the planned production expansion at Oertlis’ headquarter in Berneck, Eastern part of Switzerland.